Ghrelin for the management of cachexia associated with cancer
- 3 June 2016
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 6
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonistCancer Treatment Reviews, 2015
- Ghrelin prevents tumour‐ and cisplatin‐induced muscle wasting: characterization of multiple mechanisms involvedJournal of Cachexia, Sarcopenia and Muscle, 2015
- Pitfalls in defining and quantifying cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2011
- Ghrelin for cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2010
- Defining and Classifying Cancer Cachexia: A Proposal by the SCRINIO Working GroupJournal of Parenteral and Enteral Nutrition, 2008
- Ghrelin Treatment Causes Increased Food Intake and Retention of Lean Body Mass in a Rat Model of Cancer CachexiaEndocrinology, 2007
- Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosisThe American Journal of Clinical Nutrition, 2006
- Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cellsJournal of Clinical Investigation, 2004
- The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in ratsGastroenterology, 2002
- Meta-analyses involving cross-over trials: methodological issuesInternational Journal of Epidemiology, 2002